Edmond De Rothschild Holding S.A. Iovance Biotherapeutics, Inc. Transaction History

Edmond De Rothschild Holding S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $158,917 - $291,506	-5,543 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$28.04 - $50.26 $151,107 - $270,851	-5,389 Reduced 49.3%	5,543 $257,000
Q3 2020 Nov 12, 2020	BUY	$27.75 - $36.3 $109,390 - $143,094	3,942 Added 56.39%	10,932 $360,000
Q2 2020 Aug 07, 2020	BUY	$27.21 - $41.0 $190,197 - $286,590	6,990 New	6,990 $192,000

304

221M

3.05M

1.6M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.22B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.